Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

ClinicalTrials.gov ID: NCT01285609

Public ClinicalTrials.gov record NCT01285609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin Versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects With Stage IV/Recurrent Non Small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the lives of patients with squamous only non small cell lung cancer more than placebo plus Paclitaxel and Carboplatin.

Study identification

NCT ID
NCT01285609
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,289 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2011 (Actual)
Primary completion
Jun 9, 2015 (Actual)
Completion
Aug 22, 2017 (Actual)
Last update posted
Jun 18, 2020

2011 – 2017

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Sharp Memorial Hospital San Diego California 92123 —
Va Connecticut Healthcare System West Haven Connecticut 06516 —
Lynn Cancer Institute Center For Hematology-Oncology Boca Raton Florida 33486 —
Integrated Community Oncology Network Jacksonville Florida 32256 —
University Of Illinois At Chicago Medical Center Chicago Illinois 60612 —
Quincy Medical Group Quincy Illinois 62301 —
Presence Medical Group Hematology Oncology Skokie Illinois 60076 —
Southern Illinois University School Of Medicine Springfield Illinois 62794-9678 —
St. Francis Hospital & Health Centers Indianapolis Indiana 46237 —
Floyd Memorial Cancer Center Of Indiana New Albany Indiana 47150 —
Kentucky Cancer Clinic Hazard Kentucky 41701 —
Norton Cancer Institute Louisville Kentucky 40207 —
Montgomery Cancer Center Mount Sterling Kentucky 40353 —
St Joseph Mercy Hospital Ypsilanti Michigan 48197 —
University Of Kansas Cancer Center Kansas City Missouri 64131 —
Washington University School Of Medicine St Louis Missouri 63110 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0001 —
Clinical Research Alliance, Inc. Lake Success New York 11042 —
Durham Va Medical Center (111g) Durham North Carolina 27705 —
Carolina Biooncology Institute Huntersville North Carolina 28078 —
Novant Health Oncology Specialists Lexington North Carolina 27295 —
Gabrail Cancer Center Research Canton Ohio 44718 —
Oklahoma Oncology And Hematology, Pc Dba Tulsa Oklahoma 74146 —
Kaiser Permanente Northwest Region Portland Oregon 97227 —
Guthrie Medical Group, P.C. Sayre Pennsylvania 18840 —
Wjb Dorn Va Medical Center Columbia South Carolina 29209 —
Cancer Center Of The Carolinas Greenville South Carolina 29615 —
Associated in Oncology and Hematology Chattanooga Tennessee 37421 —
Tennessee Cancer Specialists Knoxville Tennessee 37909 —
Thompson Oncology Group Knoxville Tennessee 37916 —
Texas Oncology, PA - South Austin Cancer Center Austin Texas 78745 —
Blue Ridge Cancer Care Blacksburg Virginia 24060 —
Wisconsin Institutes for Medical Research Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 257 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01285609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2020 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01285609 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →